(2011) showed that women BRCA-mutated with BC frequently developed type-2 diabetes (11), probably because the mutation induces the loss of BRCA1 anti-tumor activity, leading to an over-activation of IGF-IR signaling pathway (12). Here, BRCA1 is linked to neoplasm.